brain injury Quadrant Biosciences Eyes 2022 Launch for Molecular Traumatic Brain Injury Test Premium The company has used RNA sequencing to discover its marker set but plans to transition the assay to a PCR platform before it seeks regulatory clearance. BU, Seqster Partner on Traumatic Brain Injury Study Newly launched aggregator Seqster will help Boston University researchers collect data from EHRs, wearables, and gene tests to identify concussion biomarkers. Cohen Veterans Bioscience, VA Partner on Brain Trauma Dx Research The partners have formed a public/private partnership to foster collaboration and data integration between different institutes researching brain trauma. Abbott in Collaborations to Develop Biomarker Test for Traumatic Brain Injury The firm wants to develop a test that can provide objective, reliable, and rapid information so that clinicians can make critical decisions in circumstances of high uncertainty. Quanterix Licenses Traumatic Brain Injury Assays From Banyan Biomarkers The company will develop the assays for its single-molecule array technology and incorporate the markers into multiplex assays for research use in neurology. Jul 19, 2016 ImmunArray Continues Lupus Rule-Out Assay Rollout, Eyes Longitudinal Testing Premium May 20, 2016 InfanDx Initiates Clinical Study for Metabolomic Perinatal Brain Damage Test Mar 30, 2016 ADx NeuroSciences, Quanterix Ink Deal to Develop Blood-Based Concussion Test Sep 10, 2015 TGen, Collaborators Awarded NIH Grant to Validate RNA Biomarkers of Brain Injury Nov 21, 2014 Sanger-led Team Sequences Patient's Brain Tapeworm Jan 23, 2014 Quanterix, Banyan Biomarkers among Winners of Research Awards for GE, NFL 'Head Health Challenge' Dec 5, 2013 NINR to Fund Studies Seeking Genomic Variants for Rehab Responses Dec 4, 2013 TGen, Barrow, Phoenix Children's Land $4M for Brain Injury RNA Sequencing Study Sep 3, 2013 Swedish Researchers Adopt Quanterix Arrays to Identify Concussion Biomarkers in Hockey Players Premium Sep 28, 2011 Emory Team Piggybacking Two Clinical Trials for Brain Injury Biomarker Studies Premium Aug 3, 2011 Emory Wins Funding for TBI Biomarker Study Apr 15, 2011 Quanterix, Gothenberg Researchers Show Potential Link Between Heart Attacks and Alzheimer's Marker Premium Mar 11, 2009 UC-Davis Spinout Arete Begins Phase II Trials for Diabetes Rx with Entomology Underpinnings Premium Mar 5, 2009 Nothing Fishy Here: Researchers Explore Use of Human Biomarker to Study Head Injuries in Salmon Premium Breaking News In Ongoing False Advertising Suit, Judge Allows Natera Counterclaims Against Guardant Health Centogene Strikes Rare Disease Target Discovery Deal With Insilico Medicine Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay Parse Biosciences Partners With Research Instruments for Southeast Asia Distribution The Scan Transplant Tests Edited Pig Kidneys The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient. UK Changes Some Gene-Edited Crop Rules A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says. Pill Works Against Omicron in Lab Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports. Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.